2. Search Result
Search Result
Results for "

mPEG

" in MedChemExpress (MCE) Product Catalog:

315

Inhibitors & Agonists

1

Fluorescent Dye

49

Biochemical Assay Reagents

31

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-400145
    mPEG45-Epoxide

    		PROTAC Linkers Others
    mPEG45-Epoxide is a PEG derivative containing polyether units. mPEG45-Epoxide can be used to synthesize PROTAC molecules .
    <em>mPEG</em>45-Epoxide
  • HY-400147
    mPEG45-diol

    		PROTAC Linkers Cancer
    mPEG45-diol is a PEG derivative containing polyether units. mPEG45-Epoxide is a PROTAC linker can be used to synthesize PROTAC molecules .
    <em>mPEG</em>45-diol
  • HY-124011
    m-PEG3-aldehyde

    		PROTAC Linkers Cancer
    m-PEG3-aldehyde is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.
    m-PEG3-aldehyde
  • HY-140676
    mPEG-amine (MW 2000)

    mPEG-NH2 (MW 2000)

    		 PROTAC Linkers Cancer
    mPEG-amine (mPEG-NH2) (MW 2000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    <em>mPEG</em>-amine (MW 2000)
  • HY-140677
    mPEG-amine (MW 5000)

    mPEG-NH2 (MW 5000)

    		 PROTAC Linkers Cancer
    mPEG-amine (mPEG-NH2) (MW 5000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    <em>mPEG</em>-amine (MW 5000)
  • HY-140678
    mPEG-amine (MW 10000)

    mPEG-NH2 (MW 10000)

    		 PROTAC Linkers Cancer
    mPEG-amine (mPEG-NH2) (MW 10000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    <em>mPEG</em>-amine (MW 10000)
  • HY-155918
    mPEG-CHO (MW 1000)

    mPEG-Aldehyde (MW 1000)

    		 Liposome Others
    mPEG-CHO (MW 1000) participates in the formation of a three-dimensional porous scaffold that carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 1000)
  • HY-155915
    mPEG-CHO (MW 350)

    mPEG-Aldehyde (MW 350)

    		 Liposome Others
    mPEG-CHO (MW 350) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 350)
  • HY-155916
    mPEG-CHO (MW 550)

    mPEG-Aldehyde (MW 550)

    		 Liposome Others
    mPEG-CHO (MW 550) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 550)
  • HY-155917
    mPEG-CHO (MW 750)

    mPEG-Aldehyde (MW 750)

    		 Liposome Others
    mPEG-CHO (MW 750) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 750)
  • HY-155919
    mPEG-CHO (MW 2000)

    mPEG-Aldehyde (MW 2000)

    		 Liposome Others
    mPEG-CHO (MW 2000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 2000)
  • HY-155920
    mPEG-CHO (MW 3400)

    mPEG-Aldehyde (MW 3400)

    		 Liposome Others
    mPEG-CHO (MW 3400) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 3400)
  • HY-155921
    mPEG-CHO (MW 5000)

    mPEG-Aldehyde (MW 5000)

    		 Liposome Others
    mPEG-CHO (MW 5000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 5000)
  • HY-155922
    mPEG-CHO (MW 10000)

    mPEG-Aldehyde (MW 10000)

    		 Liposome Others
    mPEG-CHO (MW 10000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 10000)
  • HY-155923
    mPEG-CHO (MW 20000)

    mPEG-Aldehyde (MW 20000)

    		 Liposome Others
    mPEG-CHO (MW 20000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    <em>mPEG</em>-CHO (MW 20000)
  • HY-W020780
    mPEG-Mal (MW 5000)

    mPEG-Maleimide (MW 5000); Methoxypolyethylene glycol maleimide (MW 5000)

    		 Biochemical Assay Reagents Others
    mPEG-Mal (MW 5000) is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    <em>mPEG</em>-Mal (MW 5000)
  • HY-RS08610
    MPEG1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others
    MPEG1 Human Pre-designed siRNA Set A contains three designed siRNAs for MPEG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
    MPEG1 Human Pre-designed siRNA Set A
    MPEG1 Human Pre-designed siRNA Set A
  • HY-W020780A
    mPEG-Mal (MW 350)

    mPEG-Maleimide (MW 350); Methoxypolyethylene glycol maleimide (MW 350)

    		 Biochemical Assay Reagents Liposome Others
    mPEG-Mal (MW 350) is a PEG derivative used for thiol PEGylation of protein molecules. Its maleimide group (-Mal) degrades in aqueous media and finds application in drug delivery studies.
    <em>mPEG</em>-Mal (MW 350)
  • HY-W020780B
    mPEG-Mal (MW 750)

    mPEG-Maleimide (MW 750); Methoxypolyethylene glycol maleimide (MW 750)

    		 Biochemical Assay Reagents Liposome Others
    mPEG-Mal (MW 750) is a PEG derivative used for thiol pegylation of protein molecules. Its maleimide group (-Mal) degrades in aqueous media and finds application in drug delivery studies.
    <em>mPEG</em>-Mal (MW 750)
  • HY-W020780C
    mPEG-Mal (MW 3400)

    mPEG-Maleimide (MW 3400); Methoxypolyethylene glycol maleimide (MW 3400)

    		 Biochemical Assay Reagents Liposome Others
    mPEG-Mal (MW 3400) is a PEG derivative used for thiol pegylation of protein molecules. Its maleimide group (-Mal) degrades in aqueous media and finds application in drug delivery studies.
    <em>mPEG</em>-Mal (MW 3400)
  • HY-155880
    mPEG-amine (MW 350)

    mPEG-NH2 (MW 350)

    		 Liposome Cancer
    mPEG-amine (MW 350) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR).
    <em>mPEG</em>-amine (MW 350)
  • HY-155881
    mPEG-amine (MW 550)

    mPEG-NH2 (MW 550)

    		 Liposome Cancer
    mPEG-amine (MW 550) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR).
    <em>mPEG</em>-amine (MW 550)
  • HY-155882
    mPEG-amine (MW 750)

    mPEG-NH2 (MW 750)

    		 Liposome Cancer
    mPEG-amine (MW 750) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR).
    <em>mPEG</em>-amine (MW 750)
  • HY-155883
    mPEG-amine (MW 3400)

    mPEG-NH2 (MW 3400)

    		 Liposome Cancer
    mPEG-amine (MW 3400) can synthesize folate-conjugated polymer micelles for encapsulation of anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR).
    <em>mPEG</em>-amine (MW 3400)
  • HY-155884
    mPEG-amine (MW 4000)

    mPEG-NH2 (MW 4000)

    		 Liposome Cancer
    mPEG-amine (MW 4000) can be used to synthesize folate-conjugated polymer micelles for encapsulating anticancer agent 9-nitrocamptothecin (HY-16560). folate-conjugated polymer micelles are effective carriers of insoluble anticancer drugs, which can avoid macrophages and play a role in endocytosis of tumor cells mediated by folate receptors (FR).
    <em>mPEG</em>-amine (MW 4000)
  • HY-W591476
    m-PEG-thiol (MW 1000)

    mPEG-SH (MW 1000)

    		 Liposome Others
    m-PEG-thiol (MW 1000) modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery.
    m-PEG-thiol (MW 1000)
  • HY-W591476A
    m-PEG-thiol (MW 3400)

    mPEG-SH (MW 3400)

    		 Liposome Others
    m-PEG-thiol (MW 3400) modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery.
    m-PEG-thiol (MW 3400)
  • HY-W591476B
    m-PEG-thiol (MW 750)

    mPEG-SH (MW 750)

    		 Liposome Others
    m-PEG-thiol (MW 750) modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery.
    m-PEG-thiol (MW 750)
  • HY-W591476C
    m-PEG-thiol (MW 550)

    mPEG-SH (MW 550)

    		 Liposome Others
    m-PEG-thiol (MW 550) modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery.
    m-PEG-thiol (MW 550)
  • HY-W591476D
    m-PEG-thiol (MW 350)

    mPEG-SH (MW 350)

    		 Liposome Others
    m-PEG-thiol (MW 350) modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery.
    m-PEG-thiol (MW 350)
  • HY-139819
    MPEG-PLA (PEG MW 3000 & PLA MW 50,000)

    		Biochemical Assay Reagents Others
    MPEG-PLA (PEG MW 3000 & PLA MW 50,000) is a block copolymer, which can be used to preparenanoparticles for targeted drug delivery .
    <em>MPEG</em>-PLA (PEG MW 3000 & PLA MW 50,000)
  • HY-140675
    mPEG-amine (MW 1000)

    mPEG-NH2 (MW 1000)

    		 PROTAC Linkers Cancer
    m-PEG-NH2 (MW 1000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    <em>mPEG</em>-amine (MW 1000)
  • HY-140679
    mPEG-amine (MW 20000)

    mPEG-NH2 (MW 20000)

    		 PROTAC Linkers Cancer
    m-PEG-NH2 (MW 20000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    <em>mPEG</em>-amine (MW 20000)
  • HY-140698
    m-PEG-NHS ester (MW 5000)

    mPEG-SC (MW 5000); mPEG-Succinimidyl ester (MW 5000)

    		 PROTAC Linkers Cancer
    m-PEG-NHS ester (MW 5000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    m-PEG-NHS ester (MW 5000)
  • HY-140699
    m-PEG-NHS ester (MW 10000)

    mPEG-SC (MW 10000); mPEG-Succinimidyl ester (MW 10000)

    		 PROTAC Linkers Cancer
    m-PEG-NHS ester (MW 10000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    m-PEG-NHS ester (MW 10000)
  • HY-140700
    m-PEG-NHS ester (MW 20000)

    mPEG-SC (MW 20000); mPEG-Succinimidyl ester (MW 20000)

    		 PROTAC Linkers Cancer
    m-PEG-NHS ester (MW 20000) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
    m-PEG-NHS ester (MW 20000)
  • HY-155909
    m-PEG-NHS ester (MW 3400)

    mPEG-SC (MW 3400); mPEG-Succinimidyl ester (MW 3400)

    		 Liposome Others
    m-PEG-NHS ester (MW 3400) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.
    m-PEG-NHS ester (MW 3400)
  • HY-155909A
    m-PEG-NHS ester (MW 1000)

    mPEG-SC (MW 1000); mPEG-Succinimidyl ester (MW 1000)

    		 Liposome Others
    m-PEG-NHS ester (MW 1000) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.
    m-PEG-NHS ester (MW 1000)
  • HY-155909B
    m-PEG-NHS ester (MW 550)

    mPEG-SC (MW 550); mPEG-Succinimidyl ester (MW 550)

    		 Liposome Others
    m-PEG-NHS ester (MW 550) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.
    m-PEG-NHS ester (MW 550)
  • HY-155909C
    m-PEG-NHS ester (MW 350)

    mPEG-SC (MW 350); mPEG-Succinimidyl ester (MW 350)

    		 Liposome Others
    m-PEG-NHS ester (MW 350) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.
    m-PEG-NHS ester (MW 350)
  • HY-W591424
    m-PEG-NHS ester (MW 2000)

    mPEG-SC (MW 2000); mPEG-Succinimidyl ester (MW 2000)

    		 Liposome Others
    m-PEG-NHS ester (MW 2000) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects.
    m-PEG-NHS ester (MW 2000)
  • HY-157745
    m-PEG-NHS ester (MW 40000)

    mPEG-SC (MW 40000); mPEG-Succinimidyl ester (MW 40000)

    		 Liposome Others
    m-PEG-NHS ester (MW 40000) can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects .
    m-PEG-NHS ester (MW 40000)
  • HY-120237
    m-PEG7-Amine

    		ADC Linker PROTAC Linkers Cancer
    m-PEG7-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG7-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG7-Amine
  • HY-130408
    m-PEG6-Amine

    		ADC Linker PROTAC Linkers Cancer
    m-PEG6-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG6-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG6-Amine
  • HY-130571
    m-PEG9-Amine

    		ADC Linker PROTAC Linkers Cancer
    m-PEG9-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG9-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG9-Amine
  • HY-42745
    m-PEG2-Tos

    		ADC Linker PROTAC Linkers Cancer
    m-PEG2-Tos is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG2-Tos is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
    m-PEG2-Tos
  • HY-W008429
    m-PEG2-Amine

    		ADC Linker PROTAC Linkers Cancer
    m-PEG2-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG2-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG2-Amine
  • HY-W018174
    m-PEG3-Amine

    		ADC Linker PROTAC Linkers Cancer
    m-PEG3-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG3-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG3-Amine
  • HY-W040214
    m-PEG4-Amine

    		ADC Linker PROTAC Linkers Cancer
    m-PEG4-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG4-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG4-Amine
  • HY-116186
    m-PEG5-MS

    		ADC Linker PROTAC Linkers Cancer
    m-PEG5-MS is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG5-MS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
    m-PEG5-MS

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: